X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

Genae opens offices in Dubai and announces collaboration with leading Gulf clinicians

Yuvraj_pawp by Yuvraj_pawp
10th September 2014
in Asia, News

Genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae Gulf in Dubai, and the joint effort with leading clinicians from the region, including cardiologist Dr. Ibrahim Al Rashdan.

“There is an exponentially growing demand for combining efforts between the Gulf region and the West, in terms of high quality but cost-conscious clinical research”, said Dr. Al Rashdan. “It combines the vision and guidance on evidence based medicine of our group in the Middle East with the proven CRO model of genae in the Americas and Europe.”

Dr. Al Rashdan was involved in numerous cardiovascular clinical trials as Principal Investigator and serves as Course Director of the Gulf PCR congress.

“By combining our mutual expertise in health care and clinical research, in symphony with local culture and regulations, this collaboration is truly about building bridges in the pursuit of advancing sponsored clinical trials”, said Bart Segers, CEO at genae.

Dubai is an icon of entrepreneurship and modernity in the Arab world. As the second largest emirate behind Abu Dhabi, the capital of the UAE, Dubai is globally recognized as the Middle East region’s international business hub. Since 2000 real GDP of Dubai has been growing at a CAGR of about 15%. In 2009, 95% of Dubai’s GDP came from non-oil sectors, a unique differentiator in a region where economies are dependent on oil incomes. The metropolis is offering outstanding infrastructure, a state-of-the-art telecommunications network and unparalleled connectivity.

Tags: Asia Pacific
Previous Post

Teva Pharma Issues Positive Update from Reslizumab Phase III

Next Post

Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen

Related Posts

Clinical Trials

Bio-Rad to Acquire Stilla Technologies by Q3 2025

28th February 2025
News

Types of Pharmaceutical Waste and How to Dispose of Them

31st December 2024
Developing Pharma Skills With Life Sci For Growth Initiative
News

UK Medicine Manufacturing Regulatory Framework For Care

6th November 2024
News

Nanoemulsion Drug Delivery Enhances Tuberculosis Care

6th November 2024
News

The Future of Drug Delivery Systems In Modern Medicine

6th November 2024
Revolutionizing Drug Discovery With AI For A Greener Future
News

AI and Nanotech Innovations in Advancing Drug Discovery

5th November 2024
Next Post

FDA Advisory Committee recommends against approval of Actavis' Nebivolol/Valsartan Fixed-Dose combination NDA for Treatment of Hypertension

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In